A set of transformative activities and investments is key to support delivery of the highest quality and most cost-effective care for patients, according an industry leader who spoke at the recently concluded Health Information and Management Systems Society (HIMSS) Asia Pacific Conference 2019.
How do health systems create value? This is the question posed by Dr Anne Snowdon, professor of strategy and entrepreneurship at Odette School of Business in Canada, at the recently concluded Asia Pacific Conference of the Health Information and Management Systems Society (HIMSS) 2019.
In providing value-based healthcare, the first step is to measure outcomes relevant to patients, according to a speaker who addressed healthcare professionals at the Health Information and Management Systems Society (HIMSS) Asia Pacific Conference 2019.
Focusing on value-based models of healthcare is the way forward, asserts Neil Patel, president of the consulting firm Healthbox, during his talk at the recently concluded Asia Pacific Conference of the Healthcare Information and Management Systems Society (HIMSS) 2019. This, he adds, may require reassessment of priorities and disruptions of the industry.
A digital-first approach, iConnect, allows patients to have greater access to services and guidance and enables healthcare providers to deliver much better postdischarge care, according to Lim Cher Wee, chief operating officer of the Ministry of Health, Office for Healthcare Transformation of Singapore, in his presentation at the recently concluded AsiaPac19 Conference & Exhibition of the Healthcare Information and Management Systems Society (HIMSS 2019).
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
Macrolide antibiotics are derived from the Streptomycesspecies. These contain either 14-membered (erythromycin [ERM],clarithromycin [CAM], roxithromycin [RXM]), 15-membered(azithromycin [AZM]) or 16-membered (spiramycin, josamycin,midecamycin) macrocyclic lactone rings. They inhibit proteinsynthesis by reversibly binding to the 23S ribosomal RNA (rRNA)in the 50s subunit of the bacterial ribosome. Traditionally,macrolides are used as first-line agents in respiratory, skin,soft tissue, and urogenital infections, and they are also activeagainst gram-positive cocci and atypical pathogens.
Nonsmall cell lung cancer (NSCLC) patients harbouring sensitive EGFR mutations may fare well with the third-generation tyrosine kinase inhibitor osimertinib as an upfront therapy, with the results of a network meta-analysis showing that the drug tops other currently available options in terms of progression-free survival and tolerability.
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.